Representation of sex, race, and ethnicity in pivotal clinical trials for dermatological drugs
Background: It is of paramount importance that clinical trials are designed with adequate health equity considerations to prevent disproportionate analyses of specific demographics. Objective: In this study, we investigated the representation of sex, race, and ethnicity in pivotal clinical trials fo...
Saved in:
Main Authors: | Jeffrey Ding (Author), Youwen Zhou, MD, PhD, FRCPC (Author), Muhammad Shahzeb Khan, MD, MSc (Author), Rebecca N. Sy (Author), Faisal Khosa, MD, MBA, FFRRCSI, FRCPC (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gender disparity in dermatologic society leadership: A global perspective
by: Dalia Limor Karol, MD, et al.
Published: (2021) -
The frequency of reporting race, ethnicity, and skin phototypes in dermatology case reports
by: Hye Jin Chung, MD, MMSc, et al.
Published: (2023) -
Exploring Race and Ethnicity Representational Inequities in Illinois Medical Schools
Published: (2021) -
Gender minority patients in dermatology clinical trials
by: Kyla N. Price, BS, et al.
Published: (2020) -
Rapidly progressive therapy-related myeloid neoplasm in a patient treated for Burkitt lymphoma: A case report
by: Sadaf Memon, MD, MSc, et al.
Published: (2019)